FDA
The article provides a general overview of the existing legal framework, paying attention to the most important regulatory matters.
FDA
The new article describes in detail certain specific aspects pertaining to the regulatory requirements dental composite resin devices should comply with in order to be allowed for marketing and use in the US.
FDA
The new article provides further clarification on the regulatory policy, emphasizing the key aspects to be considered in order to ensure compliance with the relevant regulatory requirements.
FDA
The new article refers to additional resources to be taken into consideration by the parties involved in operations with laboratory-developed tests.
FDA
The final article dedicated to Diversity Action Plans describes certain specific aspects pertaining to the matter, emphasizing the key considerations.
FDA
The new article is dedicated to enrollment goals, highlighting the aspects related to the rationale behind them and the way they should be measured.
